Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, phase 1/2 trial

BACKGROUND: There are few effective treatments for advanced urothelial carcinoma after progression following platinum-based chemotherapy. We assessed the activity and safety of nivolumab in patients with locally advanced or metastatic urothelial carcinoma who progressed after prior platinum-based th...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Padmanee, Callahan, Margaret K, Bono, Petri, Kim, Joseph, Spiliopoulou, Pavlina, Calvo, Emiliano, Pillai, Rathi N, Ott, Patrick A, de Braud, Filippo, Morse, Michael, Le, Dung T, Jaeger, Dirk, Chan, Emily, Harbison, Chris, Lin, Chen-Sheng, Tschaika, Marina, Azrilevich, Alex, Rosenberg, Jonathan E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648054/
https://www.ncbi.nlm.nih.gov/pubmed/27733243
http://dx.doi.org/10.1016/S1470-2045(16)30496-X

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648054/
https://www.ncbi.nlm.nih.gov/pubmed/27733243
http://dx.doi.org/10.1016/S1470-2045(16)30496-X

Ejemplares similares